Navigation Links
Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
Date:5/9/2013

al expenses

6,532773Deferred revenue 

2,7103,226Interest payable

(3,916)(1,747)Other liabilities 

(3,830)556Net cash used in operating activities 

(38,111)(34,618)Cash flows from investing activities:Maturities of investments 

100,338151,964Purchases of investments 

(56,336)(102,023)Purchases of property and equipment 

(316)(1,516)Net cash provided by investing activities 

43,68648,425Cash flows from financing activities:Payment of capital lease obligations 

(692)(566)(Repayment of) proceeds from sale of future royalties, net of transaction costs

(3,000)119,589Proceeds from shares issued under equity compensation plans

1,218479Net cash (used in) provided by financing activities 

(2,474)119,502Effect of exchange rates on cash and cash equivalents 

(7)(136)Net increase in cash and cash equivalents 

3,094133,173Cash and cash equivalents at beginning of period

25,43715,312Cash and cash equivalents at end of period

$  28,531$ 148,485Supplemental disclosure of cash flow information:Cash paid for interest

$
8,250$
4,199
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics to Present at the 33rd Annual Cowen and Company Healthcare Conference in Boston
3. Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
4. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
5. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
6. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
8. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
9. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
10. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
11. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... BerGenBio AS ("BerGenBio" or the ... has appointed Hilde Furberg and Dr ... of Directors, effective immediately. Hilde Furberg ... and biotech and is currently Senior Vice President Rare ... role was Vice President and General Manager of Nordic ...
(Date:8/31/2015)...  DICOM Grid,  the #1 medical image exchange ... as a semifinalist for a Minnie award for ... are sponsored by Auntminnie.com, a comprehensive community website ... imaging industry.  Since 1999, the "Minnies" have provided ... contributions of their peers. Nominations are made by ...
(Date:8/31/2015)... 2015 Thousands of people will peacefully demonstrate ... opioid addiction epidemic at dozens of rallies across the ... the United States has experienced ... opioids and heroin, yet the President has never once ... letter to President Obama , rally organizers compared ...
Breaking Medicine Technology:BerGenBio Appoints Non-Executive Directors 2DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2
(Date:9/1/2015)... New York, New York (PRWEB) , ... September 01, 2015 , ... ... of Zecurion Zlock Mac , its groundbreaking new version of endpoint DLP developed ... testing of Zlock Mac, in which more than 100 IT and information security professionals ...
(Date:9/1/2015)... ... September 01, 2015 , ... SC&H Group, a leading ... includes being named a “Best of the Best” firm in the U.S., as well ... the “Best of the Best” in the U.S., selected exclusively on performance in specific ...
(Date:9/1/2015)... ... September 01, 2015 , ... CanAm Enterprises LLC, (“CanAm”) ... permanent green cards (I-829 petition approval) from the USCIS through an investment in ... step of the EB-5 visa process for immigrant investors to become lawful permanent ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... popular VitaSkin™ collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of ... pillars: Firm, Bright, Calm, and Clear. , Formulated with alpha hydroxy acids ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... information about new patients directly from Practice Perfect to FOTO enabling cost and ... , Steven Presement, President of Practice Perfect, stated "FOTO is ...
Breaking Medicine News(10 mins):Health News:Zecurion Announces Endpoint Security for Mac 2Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:FOTO Announces New Integration Partnership with Practice Perfect 2
... Footprint at DaVita,s Six Corporate Business OfficesEL SEGUNDO, Calif., ... ), a leading provider of kidney care services for ... that the company is the first FORTUNE 500 healthcare ... Green Power Partnership program. Joining this program is part ...
... 2009PURCHASE, N.Y., May 12 Nutrition 21, Inc. (Nasdaq: ... nutritional supplements under the Iceland Health(R), Chromax(R) and Diabetes ... improve cardiovascular health, enhance memory and reduce chronic joint ... and the first nine months of fiscal year 2009 ...
... JENA, Germany, May 12 Occlutech, the leading European,developer of ... for its new generation ASD and PFO occluders, the Figulla ... and PFO occluders encompass a new innovative,delivery system, making the ... is facilitated by the ability of the delivery,system to allow ...
... PET/CT Viewer to Provide High Quality Viewing Capability on a ... ... PETLinQ LLC, a leading radiology solutions provider , is proud to ... pure thin client web based application created for the viewing of full ...
... care will present technology and admissions educational sessions for ACHCA ... ... May 12, 2009 --Patient Placement Systems, the leading provider of ... it will exhibit and present two sessions at the American ...
... during the earthquake require long-term specialized care to properly heal ... ... China (Vocus) May 12, 2009 -- On the one-year anniversary ... Project HOPE , an international health education and humanitarian assistance ...
Cached Medicine News:Health News:DaVita Becomes the First FORTUNE 500 Healthcare Services Company to Join the EPA Green Power Partnership 2Health News:DaVita Becomes the First FORTUNE 500 Healthcare Services Company to Join the EPA Green Power Partnership 3Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 2Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 3Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 4Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 5Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 6Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 7Health News:PETLinQ to Debut Pure Web Based PET/CT Fusion Viewer at June 2009 SNM Conference 2Health News:Patient Placement Systems Presenting Two Sessions at ACHCA 2009 Convocation 2Health News:Patient Placement Systems Presenting Two Sessions at ACHCA 2009 Convocation 3Health News:Project HOPE Launches Rehabilitation Program to Address Needs of Thousands Recovering from Injuries Sustained During the May 12, 2008 Earthquake 2Health News:Project HOPE Launches Rehabilitation Program to Address Needs of Thousands Recovering from Injuries Sustained During the May 12, 2008 Earthquake 3
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
... The Volk G-1 trabeculum provides the highest ... Perfect for viewing and treating the trabecular meshwork. ... of the anterior chamber angle while the central ... view the posterior pole for signs of glaucoma ...
... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
... The 45° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
Medicine Products: